Physician profile
Annette Mitchell
NPI 1831367531
$2,148.41
in general payments reported to CMS, 2019-2025
16 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $341 · 2022: $440 · 2023: $466 · 2024: $542 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,366.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $494.25 | 2021-2024 | Sapien 3 Ultra Resilia |
| Baxter Healthcare | $389.12 | 2022-2025 | Perclot, Floseal, Coseal |
| Novartis Pharmaceuticals Corporation | $229.32 | 2024-2025 | |
| Amgen INC. | $216.59 | 2021-2025 | Repatha |
| Philips North America LLC | $181.89 | 2023-2024 | (Ck4) Mcot |
| Janssen Pharmaceuticals, INC | $150.55 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.70 | 2022-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $116.25 | 2022-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $73.22 | 2023-2025 | Corevalve Evolut R |
| Actelion Pharmaceuticals US, INC. | $31.91 | 2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $28.80 | 2023 | Arcalyst |
| Heartflow, INC. | $24.43 | 2025 | |
| Impulse Dynamics (USA) INC. | $23.33 | 2021 | |
| Novo Nordisk INC | $23.23 | 2025 | Wegovy |
| W. L. Gore & Associates, INC. | $23.15 | 2023 | Gore Cardioform Septal Occluder |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akcea Therapeutics, INC. | $19.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annette Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.